- Filed
- Aug 7, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Aug 3, 2020 | 72.85M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 76.23M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 76.07M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 78.51M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 78.66M sh |
| Stock Repurchased | Q2 2020 · Jun 30, 2020 | $65K |
| Stock Repurchased | Q2 2020 · Jun 30, 2019 | $0 |
| Capex | Q2 2020 · Jun 30, 2020 | $233K |
| Capex restated | Q2 2020 · Jun 30, 2019 | $688K |
| Operating Cash Flow | Q2 2020 · Jun 30, 2020 | $21.11M |
| Operating Cash Flow restated | Q2 2020 · Jun 30, 2019 | $13.97M |
| Long Term Debt | Q2 2020 · Jun 30, 2020 | $28.67M |
| Long Term Debt | Q2 2020 · Dec 31, 2019 | $30.38M |
| Short Term Debt | Q2 2020 · Jun 30, 2020 | $3.5M |
| Short Term Debt | Q2 2020 · Dec 31, 2019 | $3.5M |
| Cash And Equivalents | Q2 2020 · Jun 30, 2020 | $47.64M |
| Cash And Equivalents | Q2 2020 · Dec 31, 2019 | $27.24M |
| Stockholders Equity | Q2 2020 · Jun 30, 2020 | $213.04M |
| Stockholders Equity | Q2 2020 · Mar 31, 2020 | $198.09M |
| Stockholders Equity | Q2 2020 · Dec 31, 2019 | $197.24M |
| Stockholders Equity restated | Q2 2020 · Jun 30, 2019 | $206.4M |
| Stockholders Equity restated | Q2 2020 · Mar 31, 2019 | $201.23M |
| Stockholders Equity restated | Q2 2020 · Dec 31, 2018 | $197.22M |
| Current Liabilities | Q2 2020 · Jun 30, 2020 | $43.11M |
| Current Liabilities | Q2 2020 · Dec 31, 2019 | $34.91M |
| Total Liabilities | Q2 2020 · Jun 30, 2020 | $79.56M |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $75.48M |
| Current Assets | Q2 2020 · Jun 30, 2020 | $87.34M |
| Current Assets | Q2 2020 · Dec 31, 2019 | $58.54M |
| Total Assets | Q2 2020 · Jun 30, 2020 | $292.6M |
| Total Assets | Q2 2020 · Dec 31, 2019 | $272.72M |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | $0.14 |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | $0.10 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | $0.03 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | $0.04 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | $0.14 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | $0.11 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | $0.03 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | $0.05 |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $6.66M |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $11.69M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $5.89M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $10.82M |
| Net Income | Q2 2020 · Jun 30, 2020 | $10.38M |
| Net Income | Q2 2020 · Jun 30, 2020 | $7.97M |
| Net Income restated | Q2 2020 · Jun 30, 2019 | $2.2M |
| Net Income restated | Q2 2020 · Jun 30, 2019 | $3.46M |
| Operating Income | Q2 2020 · Jun 30, 2020 | $13.93M |
| Operating Income | Q2 2020 · Jun 30, 2020 | $12.39M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | $3.44M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | $5.39M |
| Revenue | Q2 2020 · Jun 30, 2020 | $90.33M |
| Revenue | Q2 2020 · Jun 30, 2020 | $145.4M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $52M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $101.51M |